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D 2.3
Differential Diagnosis of Critical Limb Ischaemia
D 2.3.1
Differential Diagnosis of Ischaemic Rest Pain
The various causes of foot pain that may be mistaken
for ischaemic rest pain are considered in their approx-
imate order of frequency,'
Diabetic sensory neuropathy
Although diabetic neuropathy usually results in loss
of function and anaesthesia, in a minority of diabetic
patients, sensory neuropathy can result in severe, seri-
ously disabling pain in the foot. This is often described
as a burning or shooting sensation that is frequently
worse at night, making it more difficult to distinguish
from atypical ischaemic rest pain. Diagnostic features
that may be helpful are a symmetrical distribution in
both legs, association with cutaneous hypersensitivity
and failure to relieve it by dependency of the foot. The
patient may have other signs of a diabetic neuropathy,
such as decreased reflexes.
Reflexsympathetic dystrophy
Patients with reflex sympathetic dystrophy, or, as it is
commonly called, causalgia, are often mistakenly
referred to vascular surgeons or other vascular spe-
cialists. This may be fortuitous, however, because
although sympathectomy is now rarely used for CLI
or any other vascular disease (see D 4.16.6,
Sympathectomy in the Management of Critical Limb
Ischaemia, p S223), vascular surgeons have perfected
and made safe this procedure, which provides dra-
matic and lasting relief from causalgic pain. One form
of causalgic pain is caused by inadvertent ischaemic
damage to peripheral nerves after delayed revascular-
isation and therefore may be encountered as a postop-
erative complication in patients with PAD.
Although some form of trauma to peripheral nerves
is the accepted initiating cause of causalgia, the trau-
ma may be so trivial that it is missed in the history, the
patient not having made the association. Rarely it fol-
lows shingles? or some other peripheral neuritis.
Theories are numerous, but the cause is unknown.'
The diagnostic triad consists of pain (often burning),
hypersensitivity (usually along the course of a der-
matome or peripheral nerve), and autonomic imbal-
ance with vasomotor phenomena. The latter usually
consist of mottling cyanosis and hyperhidrosis, but in
early stages the limb may be warm and dry, and in late
stages, pale with trophic changes.' A mild degree of
nonpitting oedema is commonly seen as shiny skin
and is not relieved by elevation. Osteoporosis is usu-
ally seen in established cases, but this may be preced-
ed by a positive bone scan. The disuse associated with
pain avoidance may ultimately lead to ankylosis.
Before this late stage, the diagnosis may be confirmed
by a truly dramatic response to sympathetic block (ie,
close to complete pain relief), but sympathetic block
will produce some degree of amelioration in most
extremity pain. Reflex sympathetic dystrophy is not
an uncommon condition, with one large series
describing 829 patients presenting in one specialised
centre over 8 years.!
Nerve root compression
A number of spinal conditions may result in nerve
root compression, giving rise to continuous pain. It is
typically associated with backache and the pain distri-
bution following one of the dermatomes. L4 compres-
sion therefore includes pain in the big toe and dimin-
ished knee reflex. L5 compression can produce pain
on the medial edge of the foot, and Slover the exten-
sor surface of the foot with diminished ankle reflex.
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Physical examination also may show limited straight Buerger's disease
leg raising.
Buerger's disease also may present with rest pain in
the toes or foot.
Peripheral sCllsory neuropailnj other tluin diabetic IICII-
ropailu]
Any condition gIvmg rise to isolated sensory
neuropathy can produce pain in the foot, which can
be confused with ischaemic rest pain. Peripheral
neuropathy other than that caused by diabetic
neuropathy may be caused by vitamin B12 deficiency,
syringomyelia. Leprosy also may rarely result in a
neuropathic ulcer. Alcohol intake, toxins, and com-
monly used drugs may produce a rare peripheral neu-
ropathy»
Nigllt cramps
Simple night cramps, as opposed to restless legs, are
very common and occasionally difficult to diagnose.
They are usually associated with muscle spasm and
usually involve the calf, very rarely the foot alone.
They may be associated with chronic venous insuffi-
ciency, but their precise cause is unknown.
Table 38: Aetlologlcal classification of foot and leg ulcers
Venous insufficiency
Larger arteries
PAD
Emboli
Buerger's disease
Microcirculatory
Diabetic microangiopathy
Vasculitis
Collagen diseases
Neuropathic
Diabetes mellitus
Vitamin B12 deficiency
Leprosy
Table 39: Differential diagnosis of common foot and leg ulcers
Miscellaneous
A number of other miscellaneous conditions can give
rise to pain in the foot, including local inflammatory
diseases such as gout, rheumatoid arthritis, digital
neuroma, tarsal tunnel nerve compression, or plantar
fasciitis.
D 2.3.2
Differential Diagnosis of Ulcers
Table 38 is an abbreviated aetiological classification of
foot and leg ulcers. In the following text, the various
causes of ulcers are considered in approximate order
of frequency in Europe and North America? Table 39
shows the differential diagnosis of common foot and
leg ulcers.
Haematologic
Sickle cell anaemia
Polycythaemia
Leukaemia
Thalassaemia
Thrombocytopenia
Malignancy
Squamous cell carcinoma
Kaposi's sarcoma
Secondary metastases
Lymphosarcoma mycosis fungoides
Miscellaneous
Gout
Pyoderma gangrenosum
Necrobiosis Iipoidica
Drugs
Mycotic
Artifactual or factitious
Origin Calise Location Pai/! Appcara/!cE
Main arteries PAD, Buerger's, Toes, foot Severe Irregular, pale base
acute occlusion
Venous Venous disease Malleolar Mild Irregular, pink base
Skin infarct Systemic disease, Lower third of leg Severe Small after infarction,
embolism, hypertension often multiple
Neurotrophic Neuropathy Foot sole None Often deep, infected
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Venous ulcers are the long-term consequences of a
raised venous pressure secondary to chronic venous
insufficiency. Classically they were believed to fol-
low 10 to 20 years after deep vein thrombosis, but it
is now recognised that they also can arise as a result
of superficial venous incompetence without any
deep vein disease. Ulceration is usually preceded by
a long period of trophic changes in the skin, typical-
ly above the medial (internal) malleolus. Initially
there is usually hyperpigmentation, although at a
later stage, particularly after healed ulceration, the
skin can become white. Diagnosis is usually easy on
the basis of the typical site of the ulcer just above the
ankle and evidence of long-standing chronic venous
insufficiency.
Diagnostic problems usually arise with mixed
venous and arterial ulcers. The usual history is a
patient with a sequence of venous ulcers, which
gradually become more difficult to heal by the usual
methods of compression bandaging and elevation.
This may be caused by the development of signifi-
cant arterial disease superimposed on earlier venous
insufficiency. It is therefore essential to assess accu-
rately the arterial circulation in any patient who
appears to have a venous ulcer. Treatment wiII have
to be modified, because compression bandaging is
clearly inappropriate if the patient has a significant
arterial component to the ulceration. Although ath-
erosclerosis is no more common in patients with
venous ulcers than in the general population,s
patients with long-standing venous ulcers tend to be
in the age-group in which they are also likely to
develop arterial disease. Several studies have shown
that approximately 10% to 15% of venous ulcers also
have a significant arterial component.s-v
Most neuropathic ulcers occur in patients with dia-
betes, and it is often the presenting symptom of
non-insulin-dependent diabetic patients. The pure
neuropathic ulcer is easy to identify, because the arte-
rial circulation is normal. However, in patients with
diabetes, there is a whole spectrum of ulcers from the
pure neuropathic to the pure ischaemic ulcer, and
establishing the relative importance of these two
mechanisms in patients falling between the two
extremes is particularly difficult. The incidence in
patients with diabetes of pure ischaemic, pure neuro-
pathic, and mixed neuroischaemic ulcers are about
equal.» The distinction is important, because it wiII
have a bearing on the patient's treatment and progno-
sis: in the United Kingdom, 4% of hospital beds are
occupied by patients with diabetes, and 30% of these
hospitalisations are for foot problems."
In patients with diabetes, all of the components of a
neuropathy may play a part in ulceration. Sensory
neuropathy removes the protective pain sensation
after acute or chronic trauma. Abnormal pressure
points may develop on the foot because of the motor
neuropathy affecting the small muscles of the foot to a
variable extent arid producing the typical- claw
appearance seen in patients with diabetes. Pure sym-
pathetic neuropathy wiII result in a dry fissured skin
that is more prone to infection. In neuropathic ulcers,
there is usually an increased blood flow, and pure neu-
ropathic ulcers wiII heal without any form of inter-
vention, provided all pressure is removed from the
ulcerated area.
Table 40 is a guide to the differential diagnosis of the
neurological and ncuroischaemic diabetic ulcer.
Palpable pedal pulses do not rule out significant arte-
rial obstruction more distally in diabetic patients.
Table 40: Differential diagnosis of neuropathic and neuroischaemic ulcers
Neuropathic ulcer
Painless
Normal pulses
Typically punched-out appearance
Often located on sole or edge of foot
Presence of calluses
Loss of sensation, reflexes, and vibration sense
Increase in blood flow (AVshunting)
Dilated veins
Dry, warm foot
Bone deformities
Red appearance
Neuroischaemic ulcer
Painful
Absent pulses
Irregular margins
Commonly located on toes
Calluses absent or infrequent
Variable sensory findings
Decrease in blood flow
Collapsed veins
Cold foot
No bony deformities
Pale, cyanosed
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Vasculitisand collagen diseases
This is a miscellaneous group of conditions, which
have been poorly categorised. The commonest form is
associated with systemic lupus erythernatosis. The
ulcers are often multiple, small, and exquisitely ten-
der. The diagnosis may be suggested by other sys-
temic manifestations of the disease, such as renal fail-
ure. The patient may have a low-grade intermittent
fever, and blood tests often show a raised ESR and C-
reactive protein concentration. If these conditions are
suspected, further immunologic testing should be per-
formed.
Buerger's disease (ihromboangitis obliterans)
Buerger's disease is very rare in Western Europe and
North America, but it is almost as common as athero-
sclerosis in other parts of the world. It causes a pro-
gressive narrowing of the distal arteries charac-
terised histologically by an active acute inflammato-
ry appearance. There are a number of theories about
its aetiology, mostly centred around smoking, but no
definitive cause has so far been established. The
characteristic features of Buerger's disease are as
follows:
• often present with foot ulcers, claudication is rare
• onset of symptoms usually before 40 and always
before 50 years of age
• always associated with heavy smoking and usually
in young men. Usually improved by cessation of
smoking
• involves the venous system as well as the arteries.
The commonest venous manifestation is throm-
bophlebitis migrans
• may affect the upper as well as the lower limbs
• affects peripheral distal arteries and usually spares
the proximal arteries
• apart from the distal distribution of the lesions, typ-
ical arteriographic appearance shows the corkscrew
collaterals and absence of central atherosclerotic
lesions
• absence of typical risk factors for atherosclerosis
such as hyperllpidaernia
• Raynaud's phenomenon
Buerger's disease usually presents with ulceration
or necrosis at the tip of the toes or fingers. Because of
the absence of proximal disease, intermittent claudica-
tion is rare. There is no specific blood test to confirm
the diagnosis, nor a specific medical treatment, but the
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histological appearance of the small arteries and the
accompanying veins in the affected parts is typica1.13•H
Ulcers associated toiilt haemaiologic diseases
Sickle cell disease is the commonest haematologic
cause of ulceration in the feet. The incidence of ulcers
can be as high as 25% to 75% in patients with sickle
cell disease. The site is usually similar to venous
ulcers. It is a diagnosis that should be thought of in all
black patients, and specific blood tests should be per-
formed to exclude the diagnosis.» Other causes of
haematologic ulceration are acute or chronic
leukaemia, polycythaemia, and thrombocythaemia.is
Miscelianeous
• Pyoderma gangrenosum is usually associated with
inflammatory bowel disease. It begins as papules,
which rapidly turn into ulcers.
• Malignant ulcers. Almost any type of malignant
tumour, either primary to the skin or metastatic,
can occur in the foot. In addition, long-standing
venous ulcers may undergo malignant change in
which an elevated, irregular growing edge is char-
acteristic. The cutaneous lesions in Kaposi's sarco-
ma most often begin around the feet and ankles as
reddish-brown nodules that can go on to ulceration.
The two major types of lymphoma causing leg
ulceration are mycosis fungoides and lymphosarco-
ma.
• Necrobiosis lipoidica is found in approximately
0.3% of patients with diabetes.
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03
OUTCOME ASSESSMENT METHODOLOGY IN
CRITICAL LIMB ISCHAEMIA
Critical limb ischaemia represents a chronic reduction
in distal blood flow to the extent that viability of the
limb is threatened. Manifestations of this degree of
hypoperfusion include rest pain, nonhealing wounds
and ulcers, or ischaemic gangrene. Such a profound
reduction in peripheral blood flow is associated with
severe, diffuse atherosclerosis and increased likeli-
hood of death.
Despite aggressive correction of distal ischaemia,
these patients have a limited life expectancy, with less
than 60% surviving more than 3 years after treatment
1,2,3 (see A 2.7, Fate of Patients With CLI, P 521).
The therapeutic goals for the treatment of critical
limb ischaemia must reflect the clinical status of the
patient. An ideal treatment would improve both the
functional status of the leg and the life expectancy and
functional status of the patient. Unfortunately, such
interventions have not yet been developed.
Treatments must be directed both at the systemic
process, through control of risk factors, and at
improvement in distal perfusion. The extent to which
distal perfusion must be improved depends on the
general health and functional status of the patient and
the likelihood of successful improvement in these
states. The overall outcomes assessment of procedures
directed toward treatment of CLI must account for the
fragile status of this patient population.
Recommendation 80: Parameters for reporting suc-
cess of treatment for critical limb ischaemia
Success of treatment for critical limb ischaemia
should take into account an improvement in the
following:
Objective outcome: Complete healing of skin
lesions. Standardised reporting criteria should
include technical success, haemodynamic testing,
procedural morbidity, limb function, and amputa-
tion and mortality rates.
Symptomatic outcome: Relief of pain
• General quality of life: As assessed by a generic
health status instrument
• Post-revascularisation: Proof of patency of the
revascularised segment as defined in A 3.2.9,
Recommendation 5
D 3.1.1
Clinical Measures
Technical success
Technical success identifies the achievement of the
intended technical objective(s) of the complete proce-
dure. Although treatment of critical limb ischaemia
may require more than one treatment modality, for
example, thrombolytic therapy and bypass grafting,
technical success should be reported as successful
achievement of the desired result after all necessary
therapeutic procedures have been performed (see
Recommendation 51, p 5125). Technical success does
not require the restoration of palpable pedal pulses in
all cases. Many procedures, such as profundaplasty,
may provide increased distal perfusion through col-
lateral beds. Conversely, the technical inability to
carry out the intended therapeutic plan should be
reported as a technical failure. For example, the inabil-
ity to successfully lyse clot or construct a distal bypass
to a diminutive distal vessel constitutes a technical
failure.
(Repeatedfront p 5125)
Recommendation 51: Assessmellt of teellllical SIlC-
cess of multiple il/teroentiolls
Wllell' treatll~e1It inuolues multiple modalities, such
as thrombolytic tlzerapy and opel/ slirgenJ, "technical
success" should be reported as overall technical SIlC-
cess during the same hospitalisation period rather
than the success of each component of therapy,
although the success of each component of tlzerapy
also should be reported.
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